지속성 외래 복막투석 환자에서 고용량(10,000 IU) Epoetin alfa의 효과에 대한 교차 연구

키워드

참고문헌 (26)

1. "Correction of the anemia of end-stage renal disease with recombinant human erythropoietin:result of a combined phase I and II clinical trial", 316, pp.73~78 (1987)
2. "Treatment of the anemia of progressive renal failure with recombinant human erythropoietin", 321, pp.158~163 (1989)
3. "Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis", 300, pp.573~578 (1990)
4. "Long-term effects on quality of life in haemodialysis patients of corrrection of anemia with erythropoietin", 8, pp.426~432 (1993)
5. "Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients", 14, pp.478~485 (1989)
6. "Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration", 24, pp.453~460 (2004)
7. "The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta:results from a randomized controlled multicentre trial", 15, pp.2014~2019 (2000)
8. "Efficacy of once weekly epoetin alfa", 62, pp.440~448 (2004)
9. "Once-weekly epoetin alfa for treating the anemia of chronic kidney disease", 61, pp.392~405 (2004)
10. "지속성 외래 복막투석 환자에서 고용량 Epoetin Alfa의 효과", 24, pp.441~447 (2005)
11. "Morbidity and mortality of renal dialysis", 121, pp.62~70 (1994)
12. "Hematocrit levels and hospitalization risks in hemodialysis patients", 10, pp.1309~1316 (1999)
13. "Anemia and coagulopathy in therapy in nephrology and hypertension", pp.480~487 (1999), WB Saunders
14. "투석치료를 받는 만성신부전 환자의 빈혈에 대한 유전자 재조합 인 에리트로포이에틴의 임상효과", 19, pp.312~319 (2000)
15. "A randomized controlled study of iron supplementation in patients treated with erythropoietin", 50, pp.1694~1699 (1996)
16. "Management of iron deficiency in renal anemia:guidelines for the optimal therapeutic approach in erythropoietin treated patients", 48, pp.1~8 (1997)
17. "The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease", 334, pp.420~425 (1996)
18. "Effect of increased hemodialysis dose on endogenous erythropoietin production in end-stage renal disease", 79, pp.50~54 (1998)
19. "Recombinant human erythropoietin in anemic patients with end-stage renal disease:results of a phase III multicenter clinical trial", 111, pp.992~1000 (1989)
20. "National cooperative rHu erythropoietin study in patients with chronic renal failure:a phase IV multicenter study", 18, pp.24~33 (1991)
21. "Arterial hypertension in patients with chronic kidney insufficiency in hemodialysis with erythropoietin", 9, pp.119~123 (1990)
22. "The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin", 339, pp.584~590 (1998)
23. "Antibodies against recombinant human erythropoietin in a patient with erythropoietin resistant anemia", 335, pp.523~524 (1996)
24. "Assessment of pain after subcutaneous injection of erythropoietin in patients receiving haemodialysis", 303, pp.288~ (1991)
25. "Subcutaneous erythropoietin:a comparison of daily and thrice weekly administration", 88, pp.144~151 (1991)
26. "Analysis of the efficacy of measures to reduce pain after subcutaneous administration of epoetin alfa", 9, pp.1295~1298 (1994)

관련 논문AI추천